The efficacy and safety of hypofractionated radiotherapy with concurrent anti‐HER‐2 therapy following breast‐conserving therapy for breast cancer-Reference-Cited by-同舟云学术

The efficacy and safety of hypofractionated radiotherapy with concurrent anti‐HER‐2 therapy following breast‐conserving therapy for breast cancer

Published:2019-06-28 Issue:6 Volume:25 Page:1097-1103
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Dreyfuss Alexandra D.¹^ORCID,Barsky Andrew R.¹,Taunk Neil K.¹,Clark Amy S.²,Freedman Gary M.¹

Affiliation:

1. Radiation Oncology Perelman School of Medicine of the University of Pennsylvania Philadelphia Pennsylvania

2. Division of Hematology and Oncology, Department of Medicine Perelman School of Medicine of the University of Pennsylvania Philadelphia Pennsylvania

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13421

Reference15 articles.

1. Fraction size in radiation treatment for breast conservation in early breast cancer;James ML;Cochrane Database Syst Rev,2010

2. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

3. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

4. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline

5. Locoregional breast radiotherapy and concurrent treatment with trastuzumab;Jacob J;Bull Cancer,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traitements systémiques ciblés et radiothérapie locorégionale pour les cancers du sein : peut-on espérer un bénéfice de la potentialisation du traitement local ?;Cancer/Radiothérapie;2023-09

2. Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method;Medicine;2022-09-16

3. Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series;Cancers;2022-01-08

4. Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group;Medical Oncology;2021-05-10

5. Trastuzumab;Reactions Weekly;2020-01